Our research mission
The Holy Grail of many scientific and clinical efforts is to ultimately find the cure for Parkinson's disease. Although our understanding has improved over the years, many questions regarding the natural course of Parkinson’s disease and its highly variable expression remain.
At Griffith Institute for Drug Discovery are main priorities are to:
- understand the processes and mechanisms that underlie the onset and progression of Parkinson’s disease
- identify how and when Parkinson’s disease actually starts
- improve current treatment methods
- develop new methods for accurate and early diagnosis and differentiation of subtypes
- develop accurate methods for prediction and tracking of disease progression using biomarkers
- find methods to prevent further damage from happening (neuroprotection)
- find ways to slow, stop or even reverse the disease (disease modification)
- ultimately, find a cure
Translation into the community
Although basic research lies at the core of our activities at GRIDD, we also have a strong focus on translational research with more practical implications.
Translational research aims to build on basic scientific research to improve or develop new therapies, medical procedures, diagnostics and prognostics. In addition, some of that research is conducted with the purpose of improving access to and availability of adequate health services, expertise and support networks as well as new ways of delivering medical care and support at a distance or telehealth.